ClinicalTrials.govpublic full text
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
colitis, ulcerative, s1p; sphingosine 1 phosphate receptor;, ventyx; oppilan;, moderate or severe ulcerative colitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908571
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.